←Back to Expert Scholars
Translational Medicine / 转化医学Head-Neck/Esophageal Cancer Milestones
James Bonner
MD
🏢University of Alabama at Birmingham🌐USA
Professor of Radiation Oncology
72
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
James Bonner led the landmark trial demonstrating that cetuximab added to radiation improves survival in locally advanced HNSCC. This bioradiation approach became a critical treatment option for patients unable to tolerate cisplatin. His work fundamentally expanded the treatment landscape for head and neck cancer.
Share:
🧪Research Fields 研究领域
Head and neck cancer
Cetuximab-radiation
Bioradiation
Radiation oncology
HNSCC milestones
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 James Bonner 的研究动态
Follow James Bonner's research updates
留下邮箱，当我们发布与 James Bonner（University of Alabama at Birmingham）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment